Professional Documents
Culture Documents
PREPARED BY:
11049 Hardik 11069 Virendra Patel
Chaudhary 11082 Sunilkumar Mistri
11057 Hardik Shah 11086 Ami Vala
11059 Kevin Jethva 11087 Rajesh Vandar
11061 Seema 11089 Vivek Patel
Manghnani
INDIAN PHARMA SECTOR
8% of the world pharmaceutical production
In value terms, less than 2% of the world market
In volume terms – 2nd largest
In value terms –14th largest
Dominated by low priced domestically-
produced drugs
SUN PHARMA
The biggest pharma company of India by market cap
Ranked 6th by market share
No. 1 in India in 3 speciality therapy areas
Among top 3 in total of 7 therapy areas
Vertical integration
Produces raw materials through bulk drugs
production and sells them too
Direct hospital supply
Geographic expansion
17 manufacturing plants in 3 continents
Network of 400 field force in 30 countries
Field force is free to include a new village or city to
increase customer database and cater the new market
COMPETITIVE STRATEGY
Cost leadership
For few months after a launch of new product, and
after that premium pricing
Differentiation
Quality – “Effect is guaranteed.”
Niche marketing
FAMOCID Vs. PANTOCID